{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:21:09Z","timestamp":1791044469051,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ogc.2022.10.015","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:05:26Z","timestamp":1677017126000},"page":"229-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Opioids and Opioid Use Disorder in Pregnancy"],"prefix":"10.1016","volume":"50","author":[{"given":"Aalok R.","family":"Sanjanwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Krans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ogc.2022.10.015_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.015_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajog.2018.09.028","article-title":"Trends in pregnancy-associated mortality involving opioids in the United States, 2007-2016","volume":"220","author":"Gemmill","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.015_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.ogc.2022.10.015_bib5","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2021"},{"issue":"22","key":"10.1016\/j.ogc.2022.10.015_bib6","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies--tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.015_bib8","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.ogc.2022.10.015_bib9","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/add.15582","article-title":"Outcomes associated with the use of medications for opioid use disorder during pregnancy","volume":"116","author":"Krans","year":"2021","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.015_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2022.10.015_bib11","series-title":"Neuropathology of drug addictions and substance misuse","first-page":"922","article-title":"Opiate receptors and gender and relevance to heroin addiction","author":"Djurendic-Brenesel","year":"2016"},{"key":"10.1016\/j.ogc.2022.10.015_bib12","series-title":"Public policy statement: definition of addiction","year":"2011"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.015_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2012.12.007","article-title":"Gender differences in a clinical trial for prescription opioid dependence","volume":"45","author":"McHugh","year":"2013","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.ogc.2022.10.015_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2014.10.003","article-title":"Sex differences in drug use among polysubstance users","volume":"145","author":"Lewis","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"10.1016\/j.ogc.2022.10.015_bib16","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/pm\/pnw071","article-title":"Drug overdose: differing risk models for women and men among opioid users with non-cancer pain","volume":"17","author":"Liang","year":"2016","journal-title":"Pain Med"},{"key":"10.1016\/j.ogc.2022.10.015_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","article-title":"Sex and gender differences in substance use disorders","volume":"66","author":"McHugh","year":"2018","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.015_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jsat.2012.01.005","article-title":"Childhood sexual abuse characteristics, intimate partner violence exposure, and psychological distress among women in methadone treatment","volume":"43","author":"Engstrom","year":"2012","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.015_bib19","first-page":"1","article-title":"The intersection of intimate partner violence and substance use among women with opioid use disorder","volume":"42","author":"Pallatino","year":"2019","journal-title":"Subst Abuse"},{"issue":"10","key":"10.1016\/j.ogc.2022.10.015_bib20","first-page":"883","article-title":"Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders","volume":"9","author":"Tsang","year":"2008","journal-title":"J\u00a0Pain"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.015_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00002508-199309000-00004","article-title":"Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization","volume":"9","author":"Andersson","year":"1993","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.015_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1005459110063","article-title":"Gender differences in pain and pain behavior: the role of catastrophizing","volume":"24","author":"Sullivan","year":"2000","journal-title":"Cognit Ther Res"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.015_bib23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1360-0443.1994.tb03745.x","article-title":"Opiate withdrawal","volume":"89","author":"Farrell","year":"1994","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.015_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1871527311312010017","article-title":"Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets","volume":"12","author":"Rehni","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1\u20132","key":"10.1016\/j.ogc.2022.10.015_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2009.07.001","article-title":"Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument","volume":"105","author":"Tompkins","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.015_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajog.2019.07.022","article-title":"Opioids affect the fetal brain: reframing the detoxification debate","volume":"221","author":"Caritis","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.015_bib27","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy","volume":"130","author":"Mascola","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2022.10.015_bib28","series-title":"Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants","year":"2018"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.015_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsat.2010.11.007","article-title":"Higher maternal doses of methadone does not increase neonatal abstinence syndrome","volume":"40","author":"Pizarro","year":"2011","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"12","key":"10.1016\/j.ogc.2022.10.015_bib30","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.015_bib31","first-page":"93","article-title":"Changing outdated methadone regulations that harm pregnant patients","volume":"15","author":"McCarthy","year":"2021","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.ogc.2022.10.015_bib32","unstructured":"Substance Abuse and Mental Health Services Administration, Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63, Executive Summary. Publication No. PEP21-02-01-003, 2021, Substance Abuse and Mental Health Services Administration; Rockville, MD."},{"issue":"11","key":"10.1016\/j.ogc.2022.10.015_bib33","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0002-9149(02)02337-8","article-title":"Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc","volume":"89","author":"Bednar","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ogc.2022.10.015_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drugalcdep.2015.02.012","article-title":"Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder","volume":"149","author":"Wilder","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"3 Pt 1","key":"10.1016\/j.ogc.2022.10.015_bib35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ajog.2005.03.072","article-title":"High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes","volume":"193","author":"McCarthy","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ogc.2022.10.015_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin perinatology"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.015_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14767050802452291","article-title":"Maternal methadone dosing schedule and fetal neurobehaviour","volume":"22","author":"Jansson","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.015_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10826089109053183","article-title":"A\u00a0comparison of the effects of single- and split-dose methadone administration on the fetus: ultrasound evaluation","volume":"26","author":"Wittmann","year":"1991","journal-title":"Int J Addict"},{"key":"10.1016\/j.ogc.2022.10.015_bib39","unstructured":"SAMHSA, Split Dose Guidance SOTAs CSAT Final, Available at: https:\/\/www.samhsa.gov\/sites\/default\/files\/split-dose-guidance-sotas-csat.pdf. Accessed June 2022."},{"issue":"5","key":"10.1016\/j.ogc.2022.10.015_bib40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.015_bib41","doi-asserted-by":"crossref","first-page":"64 e1","DOI":"10.1016\/j.ajog.2016.09.095","article-title":"Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy","volume":"216","author":"Bastian","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.015_bib42","doi-asserted-by":"crossref","first-page":"459 e1","DOI":"10.1016\/j.ajog.2017.06.029","article-title":"An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","volume":"217","author":"Caritis","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2022.10.015_bib43","first-page":"1","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"J\u00a0Addict Med"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.015_bib44","first-page":"265","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","volume":"16","author":"Varshneya","year":"2021","journal-title":"J\u00a0Addict Med"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.015_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2010.04.001","article-title":"Factors associated with complicated buprenorphine inductions","volume":"39","author":"Whitley","year":"2010","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"5","key":"10.1016\/j.ogc.2022.10.015_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40261-021-01032-7","article-title":"The pharmacology of buprenorphine microinduction for opioid use disorder","volume":"41","author":"De Aquino","year":"2021","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.015_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","article-title":"Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs","volume":"59","author":"Volpe","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.015_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/AOG.0000000000004311","article-title":"Buprenorphine patch as a bridge to sublingual treatment of opioid use disorder in pregnancy","volume":"137","author":"Galati","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.015_bib49","doi-asserted-by":"crossref","first-page":"83 e1","DOI":"10.1016\/j.ajog.2019.07.037","article-title":"Use of naltrexone in treating opioid use disorder in pregnancy","volume":"222","author":"Towers","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ogc.2022.10.015_bib50","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.clinthera.2019.07.003","article-title":"Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects","volume":"41","author":"Wachman","year":"2019","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.015_bib51","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40265-017-0763-8","article-title":"A\u00a0Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates","volume":"77","author":"Kelty","year":"2017","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.015_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","article-title":"A\u00a0comprehensive review of opioid-induced hyperalgesia","volume":"14","author":"Lee","year":"2011","journal-title":"Pain Physician"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.015_bib53","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/AJP.0000000000000624","article-title":"A\u00a0systematic review of the processes underlying the main and the buffering effect of social support on the experience of pain","volume":"34","author":"Che","year":"2018","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ogc.2022.10.015_bib54","article-title":"A\u00a0review of peripheral nerve blocks for cesarean delivery analgesia","author":"Mitchell","year":"2019","journal-title":"Reg Anesth Pain Med"},{"issue":"9","key":"10.1016\/j.ogc.2022.10.015_bib55","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpain.2010.03.002","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","volume":"14","author":"Meyer","year":"2010","journal-title":"Eur J Pain"},{"issue":"2 Pt 1","key":"10.1016\/j.ogc.2022.10.015_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000275288.47258.e0","article-title":"Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy","volume":"110","author":"Meyer","year":"2007","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854522001061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854522001061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:25:41Z","timestamp":1760178341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854522001061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0889854522001061"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2022.10.015","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioids and Opioid Use Disorder in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2022.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}